p. 1−11
2090-7125
Vol.8/No.1
0.05). There was a correlation between the TST and MCV in both study and control groups. The 80 Hz conventional TENS was more fruitful in enhancing the autonomic and electrophysiological functions of the neuropathic tibial nerve as manifested by the increased TST and MCV than 40Hz conventional TENS.]]>
p. 12−17
2090-7125
Vol.8/No.1
p. 18−31
2090-7125
Vol.8/No.1
p. 32−36
2090-7125
Vol.8/No.1
37 weeks gestation, n=25)]. We obtained cervicovaginal swabs for fetal fibronectin and cervicovaginal fluids for cytokines determination. The present study revealed that fetal fibronectin, IL- lB and IL-8 levels were significantly higher in patients in preterm labor than in patients at preterm not in labor. They were significantly higher in women at full term in labor than in women at full term not in labor. Interleukin- lB and IL-8 obtained from women not in labor increased exponentially as gestational age increased, and the cytokines levels were significantly correlated. This study revealed that cervicovaginal measurement of fetal fibronectin, IL-lB and IL-8 in combination with clinical findings may be useful for the evaluation of patients with threatened premature delivery.]]>
p. 37−49
2090-7125
Vol.8/No.1
p. 50−61
2090-7125
Vol.8/No.1
p. 62−69
2090-7125
Vol.8/No.1
p. 70−81
2090-7125
Vol.8/No.1
p. 82−87
2090-7125
Vol.8/No.1
p. 88−93
2090-7125
Vol.8/No.1
p. 94−103
2090-7125
Vol.8/No.1
0.05) or severity (P>0.05) of PONV between the placebo and 25g/kg ondansetron group during the study period (0-24h). The incidence of early (0-2h), delayed (2-12h), and late (12-24) PONV were significantly less in the 50 (P<0.05), 75 (P<0.05) and 150 (P<0.05) g/kg ondansetron groups compared with placebo. The incidence of 24h PONV was 43, 37, 13, 10 and 7% in placebo, 25, 50, 75 and 150g/kg ondansetron groups, respectively. The PONV severity scores (0-3) were significantly less (p<0.05) in children who received ondansetron in a dose of 50g/kg or more compared with the placebo. There was no statistically significant difference with respect to the incidence (P>0.05) or the severity (P>0.05) of PONV between the 50, 75 and 150g/kg ondansetron groups. The time to first postoperative analgesic, the total postoperative analgesic consumptions, the need for RAE, the time to first oral intake and the fast tracking time (FTT) were significantly less (P<0.05) in children who received 50, 75 and 150 g/kg ondansetron in comparison with placebo. The parent’s satisfaction scores were significantly high (P<0.05) for those children who received ondansetron in a doses of 50g/kg or more compared with placebo. There was no significant difference with respect to the clinically true outcome measures in children who received ondansetron in dose of 50g/kg or more. In conclusion, ondansetron 50g/kg IV was the minimum effective IV dose to decrease the incidence and severity of PONV in dexamethasone (150g/kg IV) pretreated children undergoing adenotonsillectomy. This dose was associated with a significant reduction in the time to first postoperative analgesic, total analgesic consumptions, the need for rescue antiemetic (RAE), the time to first oral intake, the fast tracking time (FTT) and a high parent’s satisfaction scores. Increasing the dose of ondansetron to 150g/kg provided no significant benefits in reducing the incidence or severity of PONV in dexamethasone (150g/kg IV) pretreated children undergoing adenotonsillectomy]]>
p. 104−115
2090-7125
Vol.8/No.1